prostate biopsy News

A study in USA found than men over 60 years using daily these compounds reduced the risk of developing cancer prostate by 60%.

If a man is drawn to the doctor only when he appeared he was pain or notice blood in your urine, tumor growth is already the progressive stage and the chances for recovery are significantly reduced.

The World Association of Urology (AEU) does not recommend widespread screening all men over 50 years in prostate cancer from age 50 until they can discriminate tumor which threatens the life of patient since it has been shown that mass screening.

A recent Duke University study confirms that the TargetScan Touch technology by Envisioneering Medical Technologies offers effective detection and treatment of prostate cancer.

TargetScan, developed by Envisioneering Medical Technologies, accurately maps the prostate and precisely targets specific locations on the prostate.